The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 15, 2011
Filed:
Jul. 28, 2003
Lea Eisenbach, Rehovot, IL;
Boaz Tirosh, Brighton, MA (US);
Lior Carmon, Tel-Aviv, IL;
Arthur Machlenkin, Kiryat Ekron, IL;
Adrian Paz, Petach Tikva, IL;
Esther Tzehoval, Nes Ziona, IL;
Matityahu Fridkin, Rehovot, IL;
Lea Eisenbach, Rehovot, IL;
Boaz Tirosh, Brighton, MA (US);
Lior Carmon, Tel-Aviv, IL;
Arthur Machlenkin, Kiryat Ekron, IL;
Adrian Paz, Petach Tikva, IL;
Esther Tzehoval, Nes Ziona, IL;
Matityahu Fridkin, Rehovot, IL;
Yeda Research and Development Co. Ltd., Rehovot, IL;
Abstract
The invention relates to colon and prostate tumor associated antigen peptides obtainable from prostate specific G protein-coupled receptor (PSGR), six-transmembrane epithelial antigen of prostate (STEAP) and proteins encoded by genes found overexpressed in colon carcinoma cells, such as human 1-8D interferon induced transmembrane protein 2. The invention further relates to a polynucleotide encoding the tumor associated antigen peptides and to pharmaceutical compositions, which are preferably anti-tumor vaccine compositions, containing a tumor associated antigen, at least one tumor associated antigen peptide thereof, or encoding polynucleotide thereof as an active ingredient. The pharmaceutical compositions can be administered to a patient in need thereof to treat or inhibit the development of colon or prostate cancer.